Emodin-8-glucoside (CAS No 23313-21-5) is a naturally occurring anthraquinone glycoside with significant biomedical research interest particularly in oncology and anti-inflammatory studies It is derived from a variety of plant species often used in traditional medicine The compound modulates multiple signaling pathways including the inhibition of NF- B and modulation of reactive oxygen species (ROS) contributing to its therapeutic potential Emodin-8-glucoside exhibits in vitro activity typically in the nanomolar to low micromolar range making it a potent candidate for further research Its typical applications include cell-based assays and animal models for evaluating anti-cancer and anti-inflammatory effects Drug screening studies often utilize it to explore synergistic effects with other compounds Experimental concentrations typically depend on the specific research design allowing for tailored investigations into its diverse physiological actions